Apple, Inc Sr. VP and CFO sold: $28.45m-Oct 9

Luca Maestri is Apple’s senior vice president and chief financial officer reporting to CEO Tim Cook. As CFO, Luca oversees the accounting, business support, financial planning and analysis, treasury, real estate, investor relations, internal audit and tax functions at Apple. Luca joined Apple in 2013 as vice president of Finance and corporate controller, and has worked closely with Apple’s senior leadership since his arrival. Luca has over 25 years of experience building and leading finance teams in global companies with significant operating scale and complexity. Prior to joining Apple, Luca was CFO at Xerox and previously at Nokia Siemens Networks. He began his career with General Motors and spent 20 years in finance and operating roles in the Americas, Asia Pacific and Europe. While at GM, Luca was part of the team that established GM’s regional Asia Pacific operations, including manufacturing investments in China and Thailand. He later became CFO for all of GM’s operations in Europe, which spanned over 45 countries with annual net revenue of approximately $40 billion.

Luca graduated from Luiss University in Rome with a bachelor’s degree in Economics and earned a master’s degree in Science of Management from Boston University.

https://www.apple.com/leadership/luca-maestri/

https://www.finviz.com/insidertrading.ashx?oc=1513362&tc=7&b=2

>>11057247

Guardant Health sold by Softbank Vision Fund: $707.57m-Oct 9

Guardant Health : Announces Pricing of Public Offering of Common Stock by Selling Stockholder

Guardant Health, Inc. (Nasdaq: GH) (“Guardant Health”), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, announced today the pricing of an underwritten public offering of 7,000,000 shares of its common stock at a public offering price of $102.00 per share, before deducting underwriting discounts and commissions, all of which are being sold by SoftBank Investment Advisers. In addition, SoftBank Investment Advisers has granted the underwriter a 30-day option to purchase up to 700,000 additional shares of common stock at the public offering price, less underwriting discounts and commissions. Guardant Health is not selling any of its shares in the offering and will not receive any of the proceeds from the sale of shares in the offering by SoftBank Investment Advisers. The offering is expected to close on October 9, 2020, subject to the satisfaction of customary closing conditions. J.P. Morgan Securities LLC is acting as sole book-running manager of the offering.

https://www.marketscreener.com/quote/stock/GUARDANT-HEALTH-INC-46434671/news/Guardant-Health-Announces-Pricing-of-Public-Offering-of-Common-Stock-by-Selling-Stockholder-31498153/

Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. It provides Guardant Health Oncology Platform. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant360 is a molecular diagnostic test that measures 73 cancer-related genes from circulating tumor deoxyribonucleic acid (ctDNA). Its Guardant360 process includes blood collection, laboratory processing, analysis and reporting. Guardant360 is used for a range of applications, including translational science research and identifying target patient populations, drug development and commercialization post-drug approval. Number of employees : 622 people.

https://www.finviz.com/insidertrading.ashx?oc=1782391&tc=7&b=2

https://www.sec.gov/Archives/edgar/data/1576280/000089924320028065/xslF345X03/doc4.xml

Mexico's Cemex extends $2 bln loan maturities in 'green' finance deal

Mexican cement maker Cemex said in a statement on Tuesday that it has extended repayment dates on about $2.1 billion of credit and will prepay some $530 million in loans, as part of a so-called “green” financing deal.

Cemex also changed some $313 million of dollar-denominated credit to Mexican pesos and around $82 million to Euros in the deal, under which the company incorporated green metrics into approximately $3.2 billion of commitments.

Cemex said the transaction meant it had no important debt maturities through July 2023.

“We are pleased with this transaction, which allows us to improve our debt maturity profile and underscores Cemex’s commitment to sustainability as one of our key strategic pillars,” said chief financial officer Maher Al-Haffar.

The green metrics include reducing net CO2 emissions related to cement products and power consumption from green energy. Performance in respect to the metrics could result in adjustments of interest rate margins of up to 5 basis points, Cemex said.

https://www.reuters.com/article/cemex-debt/update-1-mexicos-cemex-extends-2-bln-loan-maturities-in-green-finance-deal-idUSL1N2H42BZ

>>11057455

>>11057663

>>>11057037 - What is JIDF?

>>11057703

>>11057747